AGL Relative Valuation
AGL's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, AGL is overvalued; if below, it's undervalued.
Historical Valuation
agilon health inc (AGL) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.16 is considered Undervalued compared with the five-year average of -29.82. The fair price of agilon health inc (AGL) is between 3.37 to 49.59 according to relative valuation methord. Compared to the current price of 2.35 USD , agilon health inc is Undervalued By 30.06%.
Relative Value
Fair Zone
3.37-49.59
Current Price：2.35
30.06%
Undervalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
2.01
P/B
Median3y
5.52
Median5y
4.13
-5.56
FCF Yield
Median3y
-5.24
Median5y
-4.07
Competitors Valuation Multiple
The average P/S ratio for AGL's competitors is 0.62, providing a benchmark for relative valuation. agilon health inc Corp (AGL) exhibits a P/S ratio of 0.16, which is -73.56% above the industry average. Given its robust revenue growth of -4.46%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
FAQ
Is agilon health inc (AGL) currently overvalued or undervalued?
What is agilon health inc (AGL) fair value?
How does AGL's valuation metrics compare to the industry average?
What is the current P/B ratio for agilon health inc (AGL) as of Jul 08 2025?
What is the current FCF Yield for agilon health inc (AGL) as of Jul 08 2025?
What is the current Forward P/E ratio for agilon health inc (AGL) as of Jul 08 2025?